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Abstract: Calcium intake during adolescence is important for attainment of peak bone mass.
Lactose maldigestion is an autosomal recessive trait, leading to lower calcium intake. The Adequate
Calcium Today study aimed to determine if a school-based targeted behavioral intervention over one
year could improve calcium intake and bone mass in early adolescent girls. The school-randomized
intervention was conducted at middle schools in six states over one school year. A total of
473 girls aged 10–13 years were recruited for outcome assessments. Bone mineral content (BMC)
was determined by dual energy X-ray absorptiometry. Dietary calcium intake was assessed with
a semi-quantitative food frequency questionnaire. Baseline calcium intake and BMC were not
significantly different between groups. After the intervention period, there were no differences in
changes in calcium intake and BMC at any site between groups. An unanticipated outcome was a
greater increase in spinal BMC among lactose digesters than lactose maldigesters in the intervention
schools only (12 months) (6.9 ± 0.3 g vs. 6.0 ± 0.4 g, p = 0.03) and considering the entire study
period (18 months) (9.9 ± 0.4 vs. 8.7 ± 0.5 g, p < 0.01). Overall, no significant differences between
the intervention and control schools were observed. However, lactose digesters who received the
intervention program increased bone mass to a greater extent than lactose maldigesters.
Keywords: adolescents; bone; calcium; perceived milk intolerance; lactose maldigestion
1. Introduction
The National Osteoporosis Risk Assessment identified Asian, Hispanic, and non-Hispanic white
women as being at higher risk for osteoporosis compared with non-Hispanic Black women [1]. At least
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90% of peak bone mass is achieved by age 18 years in girls [2]; thus, calcium intake during childhood
and adolescence is an important factor in reaching peak bone mass in early adulthood.
According to the Institute of Medicine, the Dietary Reference Intake for calcium for adolescent
girls is a Recommended Dietary Allowance of 1300 mg [3]. National surveys have demonstrated a
decline in dietary calcium intake among girls as they progress through adolescence [4]. Dairy foods are
known as an excellent source of calcium. Some barriers hindering the consumption of dairy foods are
perceived milk intolerance (PMI), lactose intolerance, and lactose maldigestion (LM). Several studies
have suggested an association between these barriers and low calcium intakes, and the incidence of
osteoporosis [5–10].
Intervention studies using milk, calcium supplements, or calcium rich foods have been conducted
to investigate a direct relationship between calcium intake and bone mass in prepubertal children [11–14].
Although the intervention amount of calcium has been varied, these studies have consistently
demonstrated a positive association between calcium intake and bone mass in prepubertal
children [11–14]. However, the benefits of the supplementation were rapidly lost after the intervention
ceased [15]. The supplementation studies provided a short-term intervention that did not focus on
changing food behaviors. In contrast, French et al. implemented a well-designed, group-randomized
behavioral intervention to improve calcium intake among early adolescent girls [16]. The results
revealed small, significant changes in calcium intake but no significant benefit to bone mass. Thus,
the question remained of whether a behavioral intervention could have the same positive effect
as supplementation.
Our primary hypothesis was that early adolescent girls receiving a behavioral calcium
intervention would increase calcium intake and improve bone mass compared with girls not receiving
the intervention. The secondary hypothesis was that LM, as an obstacle to achieving adequate
calcium intake, can be overcome by a behavioral intervention, resulting in changes in dietary calcium
intake and bone mass among maldigesters that are similar to those of digesters. The study was designed
to allow for examination of whether the intervention outcomes persisted past the intervention.
2. Materials and Methods
2.1. Study Design and Sample Selection
A school-randomized behavioral intervention study called the Adequate Calcium Today (ACT)
project was conducted in sixth grade classrooms located in six states (Arizona, California, Hawaii,
Indiana, Nevada, and Ohio) from September 2000 through September 2004. Middle schools within
one-hour driving time of one of the designated dual energy X-ray absorptiometry (DXA) measurement
sites were eligible to participate in the study if their student population had a higher proportion
of Asian or Hispanic students than the respective state’s average. A recruitment goal for the
total number schools was to enlist at least two pairs of schools within each state, for a total of
16 matched sets. Once schools agreed to participate, they were paired based on likeness in race/ethnic
distribution and participation in free or reduced-price school lunches. Within a pairing, schools were
randomly assigned to an intervention or a control group using the randomized complete block design.
The randomization was done by the Data Coordinating Center at Purdue University. Outcomes
assessors (i.e., DXA technicians) were blinded; however, participants could not be blinded to their
group assignment. In some cases, two or more schools were recruited and pooled to reach adequate
numbers and comparable ethnic distribution. The final groups consisted of seven pairs with two
schools and seven pairs with three schools. No schools dropped out of the study during the project.
The primary outcome measures were collected on a subset of girls in the sixth grade. Girls were
recruited through posters, presentations and invitations mailed to all sixth-grade girls registered in
the participating schools. Girls recruited for evaluation measures were limited to those identifying
ancestry as Asian (at least 75%), Hispanic or non-Hispanic white, based on the race/ethnicity of
their biological parents. Of the 848 girls recruited, 748 met the ethnic group criteria (Figure 1).
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The institutional review boards of the participating site in each state approved the study protocol,
and written informed consent was obtained from the girls and their parents. At the beginning of
the school term, prior to the first intervention lesson, girls were measured. The measurements were
repeated at 12 months ± 2 weeks and 18 months ± 4 weeks after the first measure. This trial has been
registered at www.clinicaltrials.gov (Identifier: NCT02202889).
Figure 1. Consort diagram of participants included for analysis in the Adequate Calcium Today project;
1 Inclusion criteria of ethnic group not met; 2 Breath hydrogen test (BHT) was needed for classification
of lactose maldigestion status
2.2. Sample Size Estimation
The sample size estimates were based on calculations from information in the literature available
at the time that the study was designed [11,17]. The effects of a previous intervention were very
similar for bone mineral content (BMC) and bone mineral density in a population very similar to the
current study. Therefore, sample size calculations used 2.5% and 4.7% as the standard deviations in
the percent change from baseline for total bone mineral density and lumbar spine density, respectively.
With 75 individuals in each group (intervention and control, with three ethnic groups, this implied a
total of 450 participants), we had at least an 80% chance of declaring the intervention successful when
the difference in change of total bone mineral density from baseline was 1.16% or more; 90% when it
was 1.33% or more. The comparable values for lumbar spine density were 2.17% and 2.51%.
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2.3. Intervention Implementation
All sixth-grade boys and girls in the intervention schools received the intervention lessons;
the boys received the intervention lessons in order to minimize disruption in the intervention schools.
The control schools did not receive any intervention messages. Schools were asked to avoid
participating in milk promotion campaigns during the intervention period. The ACT intervention
program consisted of six sessions of 50 min each that were provided throughout the school year,
with at least two-week intervals between sessions [18]. At school sites, the program was referred to
as only “ACT” to minimize influence beyond the intervention. To insure consistency among sites,
the sessions were conducted by trained research staff with classroom teachers present. The sessions
were delivered via DVD (video portion) and CD (game portion). The objective of the program
was to motivate changes in dietary behavior to increase the consumption of calcium rich foods,
including traditional dairy sources and non-dairy sources relevant to Hispanic and Asian populations.
The program used the ‘No Bones About It’ package which includes information about calcium
and bone health, how to build skills for choosing calcium rich foods, motivational messages from
role models, and opportunities for action planning and reflection. The intervention was developed
based on a transtheoretical model [19]. According to research using this model [19], people pass
through specific stages, each with its own characteristic cognitive, behavioral, and social processes
and strategies, on their way to achieving and maintaining a behavior change. The intervention sessions
were developed with two organizing logics: instructional logic [20] and behavioral stages logic [19].
Instructional logic is the classic approach to education in which basic concepts are introduced and
proceed to more complex concepts. Bridging concepts are repeated for reinforcement. Behavioral
stages logic is part of the transtheoretical model in which individuals undergo stages of readiness in
accepting and adopting a new behavior.
2.4. Anthropometric Measures and Maturity
Anthropometric measurements included weight, standing and sitting heights, forearm and
femur lengths, waist circumference, waist depth, and bitrochanteric width. All measurements were
performed following the procedures in the Anthropometric Standardization Reference Manual [21],
and details of the quality control methods used have been previously described [22]. For the purpose
of this analysis, height and weight taken at baseline and changes in height and weight were used.
Changes in height and weight were calculated as the height or weight at visit date (12 or 18 months)
minus the height or weight at baseline.
Breast and pubic hair pubertal staging was done using line drawings based on Tanner reference
stages [23]. In a private setting, girls self-reported the stages on a scale of 1–5, 1 being prepubertal and
5 being fully mature for each area of breast and pubic hair. An average of breast and pubic hair scores
was used for an average Tanner value. Postmenarcheal age was calculated as the visit date minus
menarcheal date and divided by 365. For this analysis, postmenarcheal age was used as a measure
of maturation.
2.5. LM Status and PMI Status
LM was measured using a breath hydrogen test (BHT). Of the 748 eligible girls, 495 (66%)
completed the BHT (Figure 1). The majority who did not complete BHT were from the Ohio site
(n = 151). Details of the BHT used have been previously described by Matlik et al. [10]. As an
initial standard, an increase of hydrogen >20 ppm above baseline was considered positive for
LM. A constant elevation of hydrogen over the three-hour period was also considered positive
for LM. The results for 22 girls who did not stabilize at a low concentration of hydrogen were
considered indeterminate.
The PMI status and score were determined using methods described by Matlik et al. [10].
A questionnaire consisting of three statements was used: (1) I am allergic to milk; (2) I get a stomachache
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after drinking milk; and (3) I have been told that milk will make my stomach hurt after I drink it.
Girls responded based on a scale of 1–5, 1 being “strongly disagree”, 5 being “strongly agree”; and
“do not know” scored as missing. During several pilot tests with early adolescents, the statements
were found to be satisfactory in terms of reliability by using test/retest (r = 0.53; p < 0.001; paired t test,
p > 0.05) and internal consistency (Cronbach’s α = 0.68) analyses. An average of the responses was
used for classifying PMI status if there were ≥2 non-missing responses. A score of >2 was defined to
be indicative of PMI, as used previously [10].
2.6. Bone Mineral Assessment
At baseline and follow-up measurement visits, DXA [24] was used to determine BMC,
bone mineral density, and bone area for total body, lumbar spine L2–L4, and left and right femurs.
Measurements were performed following standardized procedures. Phantom measurements were
reviewed independently at the University of California, San Francisco to determine within-laboratory
and between-laboratory variance in DXA measurements. Details of bone measurements and quality
control methods have been previously described [22]. In the present study, BMC for total body,
lumbar spine L2–L4, total hip, and hip femoral neck were reported and analyzed.
2.7. Dietary Assessment
At baseline and follow-up measurement visits, dietary calcium intakes from the past month
were estimated using a semi-quantitative food frequency questionnaire (FFQ) developed for,
and evaluated with, Asian, Hispanic, and non-Hispanic White youth [25,26]. Compared with two
24-h recalls, this questionnaire had high reliability (r = 0.68; p < 0.001) and accuracy (r = 0.54; p < 0.001).
Daily calcium intakes from the 78 items listed in the FFQ were categorized in five ways. This included
the intake of calcium exclusively from dairy foods (e.g., milk which is exclusively dairy calcium),
and calcium intake from non-dairy foods (e.g., broccoli, tofu, soy milk, polenta, posole, miso).
Another category was calcium intake from both dairy and non-dairy sources which was labeled
as “calcium from mixed foods”. Examples of this grouping are pizza or cheese enchiladas where
calcium from the cheese is from a dairy source and calcium from the crust/wrap, sauce, and any
vegetables are from a non-dairy source. The category, “total dairy calcium”, was the sum of the calcium
from the exclusive dairy foods and mixed foods groups. Finally, the category, “total dietary calcium”,
was the sum of calcium from exclusive dairy foods, nondairy foods, and mixed foods groups. For the
purposes of this analysis, total dietary calcium, total dairy calcium, and calcium exclusively from dairy
foods were examined. Estimated total dietary calcium intakes that were <100 mg/day or >2500 mg/day
were considered implausible and were excluded from analyses.
2.8. Statistical Analyses
Data were analyzed using Statistical Package for the Social Sciences [27]. Before parametric
analyses were done, probability plots were used to assess the normality of distribution. No variables
required a transformation. Time periods examined were as follows: baseline to 12 months (influence
of intervention), 12 months to 18 months (maintenance of intervention), and baseline to 18 months
(overall influence of intervention).
The primary outcome, change in BMC, was analyzed using a general linear regression. A common
model was used for all bone sites (i.e., total body, spine L2–L4, total hip, and femoral neck). Treatment,
LM status, PMI status, and race were considered to be fixed effects. Schools in the same state were
paired based on comparable ethnic distribution and assigned as intervention or control schools.
The school blocks were also nested within states, which made it impossible to separate out the two
factors in the model. Therefore, state was eliminated from the model and school blocks were included
in the model and considered to be a random effect. We excluded participants with missing values
for LM or PMI (n = 275). Data for 473 girls were analyzed. Post-menarcheal age and state were
used as covariates. Other covariates included were baseline value for each endpoint, baseline age,
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baseline height, change in height at 12 or 18 months, post-menarcheal age at 12 or 18 months, race,
and state.
A similar approach was used to examine the primary behavioral outcome variable: change in
dietary calcium intake. Misreporters or outliers were eliminated prior to the analysis of changes in
dietary calcium intake (n = 63). A common model was used for the three dietary calcium measures
(i.e., total dietary calcium, total dairy calcium, and exclusive dairy calcium). Models in which
a change in dietary calcium was examined included terms for treatment, LM status, PMI status,
baseline value for each endpoint, baseline age, baseline weight, change in weight at 12 or 18 months,
race, and school blocks. Baseline bone status and dietary calcium intake according to intervention
status were examined by using two-sample t tests.
For the secondary outcome analyses, girls in the intervention group were further analyzed by
LM status. Changes in BMC and dietary calcium intake were examined while adjusting for the
aforementioned covariates. p < 0.05 and p < 0.10 were considered statistically significant and a trend
towards significance, respectively.
3. Results
3.1. Descriptive Characteristics
The demographic, and physical and behavioral variables of participants by treatment group
condition at baseline, 12 months, and 18 months are shown in Table 1. The retention rate was high
throughout the study period. Of the 473 girls enrolled at baseline, 466 (98.5%) participated at 12 months
and 438 (92.6%) participated at 18 months. At baseline, 181 girls and 292 girls were in the control
and intervention groups, respectively. Race/ethnic groups were similarly represented: 31.7% Asian,
38.1% Hispanic, and 30.2% non-Hispanic White. However, more Asian girls and less Hispanic girls
were in the intervention group than the control group. At baseline, the average age was 11.7 years and
body mass index was 20.6 kg/m2.
Of the 466 girls who completed a perceived milk intolerance questionnaire, only 64 girls (13.7%)
perceived themselves as being milk intolerant, and there was no difference in the proportions across
race/ethnic groups (X2 = 0.15, df = 2, p = 0.93). In the BHT, 159 of 473 girls (33.6%) were found to
be lactose maldigesters. LM was more predominant in the Asian (n = 80) and Hispanic (n = 67) girls
compared with Non-Hispanic White girls (n = 12) (X2 = 67.96, df = 2, p < 0.0001). Sixty-one lactose
maldigesters were in the intervention group, and 98 lactose maldigesters were in the control group.
Of the 473 participants measured at baseline, 471 completed the FFQ, and data from
411 participants were included in the analysis after excluding outliers (n = 60). At follow-up visits at 12
and 18 months, completed FFQs were collected from 456 and 436 participants, respectively. Among the
collected FFQs, data from 407 and 406 participants were included in the analyses after excluding
outliers (n = 49 at 12 months and n = 30 at 18 months, respectively.) There were no statistical differences
between the intervention and control groups with regard to physical development, age, and body
mass index measured at baseline and follow-up visits.
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Table 1. Demographic and physiological variables among early adolescent girls by treatment group at
baseline and follow-up.
Baseline 12 Months 18 Months
Group a C I C I C I
Total Participants (n) 181 292 176 290 164 274
Race/Ethnic Group (n)
Asian (%) 45 (25) 105 (36) 43 (24) 104 (36) 43 (26) 104 (38)
Hispanic (%) 81 (45) 99 (34) 78 (44) 98 (34) 68 (41) 86 (31)
Non-Hispanic White (%) 55 (30) 88 (30) 55 (32) 88 (30) 53 (33) 84 (31)
Location (n)
Arizona 51 71 49 70 39 56
California 39 81 38 80 38 78
Hawaii 30 81 29 81 29 81
Indiana 50 50 49 50 47 50
Nevada 11 9 11 9 11 9
Physical Development b
Tanner Score 2.43 ± 0.97 2.41 ± 0.82 3.13 ± 0.97 3.09 ± 0.97 3.32 ± 0.91 3.30 ± 0.88
Tanner Upper 2.25 ± 1.01 2.25 ± 0.87 2.89 ± 1.07 2.88 ± 1.09 3.07 ± 1.03 3.06 ± 0.98
Tanner Lower 2.61 ± 1.12 2.58 ± 1.01 3.37 ± 1.08 3.33 ± 1.04 3.58 ± 0.94 3.55 ± 1.05
Age b (years) 11.7 ± 0.44 11.7 ± 0.46 12.8 ± 0.44 12.7 ± 0.46 13.3 ± 0.45 13.2 ± 0.47
BMI b (kg/m2) 20.6 ± 4.56 20.5 ± 4.70 21.5 ± 4.79 21.4 ± 5.08 21.9 ± 4.77 21.9 ± 5.18
Complete PMI c
questionnaire 179 287 - - - -
Positive for PMI c 22 42 21 42 20 39
Completed BHT c 181 292 - - - -
Lactose maldigester d (%) 61 (34) 98 (34) 59 (34) 98 (34) 58 (35) 93 (34)
Completed FFQ c 181 290 174 282 163 273
FFQ excluding outliers e 160 251 157 250 153 253
a Differences between intervention and control groups (I = intervention; C = Control); values are means ± SDs and
were obtained using the two-sample t test in SPSS; no statistical difference between control and intervention groups
(p > 0.05); b data are means ± standard deviations; c perceived milk intolerance (PMI), breath hydrogen test (BHT),
food frequency questionnaire (FFQ); d based on completed breath hydrogen test measured at baseline; e based on
completed food frequency questionnaires. Girls with dietary calcium intakes <100 mg or >2500 mg were excluded
as outliers.
3.2. Effects of the Intervention on Bone Mass Gains
Treatment-related changes in BMC for each bone site are shown in Table 2. There were no statistically
significant group differences for changes in BMC for each site (p > 0.05). For the subgroup analyses,
the participants in the intervention group were further analyzed to investigate the treatment effects
based on LM status (Table 3).
There was a greater increase in BMC in the spine (L2–L4) among lactose digesters (LD) compared
with lactose maldigesters over a one-year intervention period (lactose maldigesters vs. lactose digesters:
6.0 ± 0.4 vs. 6.9 ± 0.3 g, p = 0.03) and during the entire 18-month study period (lactose maldigesters vs.
lactose digesters: 8.7 ± 0.5 vs. 9.9 ± 0.4 g, p < 0.01). In addition, a similar trend was seen for the change
in BMC at the hips (total) among lactose digesters compared with lactose maldigesters after 12 months
of the intervention (lactose maldigesters vs. lactose digesters: 2.9 ± 0.2 vs. 3.3 ± 0.2 g, p = 0.09).
Changes in BMC at other sites between LM and LD were not significantly different. In addition, for the
participants in the control group, there were no statistically significant differences in changes in BMC
at all sites based on lactose digestion status (See Appendix A, Tables A1 and A2).
For the subgroup analyses based on PMI status, there were no differences between girls with PMI
and without PMI with regard to changes in BMC at all sites (data not shown).
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Table 2. Calcium intake and bone mass among early adolescent girls by treatment group at baseline and change at follow-up visits a.
Control Intervention Group Differences b, p
Baseline ∆0–12Months
∆12–18
Months
∆0–18
Months Baseline
∆0–12
Months
∆12–18
Months
∆0–18
Months
∆0–12
Months
∆12–18
Months
∆0–18
Months
Dietary calcium intake c, mg
Total dietary calcium 1123 ± 56 −92 ± 64 −40 ± 64 −76 ± 70 1052 ± 566 −39 ± 51 −89 ± 54 −188 ± 54 0.42 0.47 0.17
Total dairy calcium 947 ± 489 −85 ± 57 −32 ± 59 −72 ± 62 895 ± 521 −39 ± 45 −75 ± 49 −176 ± 48 0.45 0.49 0.16
Exclusively dairy calcium 650 ± 390 −87 ± 48 −20 ± 51 −59 ± 55 632 ± 416 −51 ± 38 −22 ± 43 −131 ± 42 0.51 0.97 0.28
Bone mineral content d, g
Total body 1595 ± 372 293 ± 19 108 ± 14 388 ± 21 1585 ± 397 275 ± 15 107 ± 12 390 ± 17 0.45 0.92 0.93
Total hip 24 ± 5 2.8 ± 0.2 0.9 ± 0.1 3.8 ± 0.2 23 ± 5 3.1 ± 0.2 0.9 ± 0.1 4.2 ± 0.2 0.20 0.51 0.08
Spine (L2–L4) 28 ± 7 6.4 ± 0.4 2.6 ± 0.2 9.0 ± 0.4 28 ± 8 6.4 ± 0.3 2.6 ± 0.2 9.3 ± 0.3 0.92 0.95 0.58
Femoral neck 4 ± 0.7 0.47 ± 0.03 0.20 ± 0.02 0.66 ± 0.04 4 ± 0.7 0.46 ± 0.02 0.17 ± 0.02 0.66 ± 0.03 0.91 0.29 0.99
a Values are means ± standard deviations for group differences at baseline from two-sample t tests; values are means ± standard errors for changes in calcium intake and bone mass based
on a general linear model; b group differences represent the differences between intervention and control groups; c model was adjusted for lactose maldigestion (LM), perceived milk
intolerance (PMI), school blocks, race, baseline value for outcome, baseline age, baseline weight, and change in weight at 12 or 18 months; girls with dietary calcium intakes <100 mg or
>2500 mg were excluded as outliers and were removed from analysis; d model was adjusted for LM, PMI, school blocks, race, baseline value for outcome, baseline age, baseline height,
change in height at 12 or 18 months, and post-menarcheal age.
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Table 3. Calcium intake and bone mass among early adolescent girls in the intervention group based on lactose digestion status at baseline and change at follow-up
visits a.
Lactose Maldigesters Lactose Digesters Group Differences b, p
Baseline ∆0–12Months
∆12–18
Months
∆0–18
Months Baseline
∆0–12
Months
∆12–18
Months
∆0–18
Months
∆0–12
Months
∆12–18
Months
∆0–18
Months
Dietary calcium intake c, mg
Total dietary calcium 1126 ± 580 −53 ± 74 −165 ± 77 −209 ± 77 1014 ± 557 12 ± 59 −75 ± 61 −151 ± 61 0.39 0.27 0.46
Total dairy calcium 957 ± 530 −55 ± 66 −149 ± 71 −204 ± 68 864 ± 516 −5 ± 52 −57 ± 56 −148 ± 54 0.46 0.29 0.42
Exclusively dairy calcium 653 ± 399 −59 ± 55 −84 ± 64 −156 ± 61 622 ± 425 −41 ± 43 12 ± 51 −110 ± 48 0.74 0.16 0.45
Bone mineral content d, g
Total body 1535 ± 392 273 ± 22 108 ± 15 393 ± 24 1610 ± 398 279 ± 17 115 ± 12 404 ± 20 0.76 0.63 0.65
Total hip 22 ± 5 2.9 ± 0.2 0.9 ± 0.1 4.2 ± 0.2 23 ± 5 3.3 ± 0.2 1.0 ± 0.1 4.4 ± 0.2 0.09 0.51 0.33
Spine (L2–L4) 27 ± 8 6.0 ± 0.4 2.3 ± 0.2 8.7 ± 0.5 28 ± 8 6.9 ± 0.3 3.0 ± 0.2 9.9 ± 0.4 0.03 * <0.01 * <0.01 *
Femoral neck 3 ± 1 0.43 ± 0.04 0.16 ± 0.02 0.64 ± 0.04 4 ± 0.7 0.49 ± 0.03 0.19 ± 0.02 0.70 ± 0.03 0.09 0.16 0.14
a Values are means ± standard deviations for group differences at baseline from two-sample t tests; values are means ± standard errors for changes in calcium intake and bone mass
based on a general linear model; b group differences represent the differences between lactose digesters and lactose maldigesters; c model was adjusted for lactose maldigestion (LM),
perceived milk intolerance (PMI), school blocks, race/ethnicity, baseline value for outcome, baseline age, baseline weight, and change in weight at 12 or 18 months; girls with dietary
calcium intakes <100 mg or >2500 mg were excluded as outliers and were removed from analysis; d model was adjusted for LM, PMI, school blocks, race/ethnicity, baseline value
for outcome, baseline age, baseline height, change in height at 12 or 18 months, and post-menarcheal age; * p < 0.05.
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3.3. Effects of the Intervention on Dietary Calcium Intake
Changes in dietary calcium intake based on treatment group are shown in Table 2. There were no
significant differences in dietary calcium intake between girls in the intervention group and those in
the control group. Table 3 shows changes in dietary calcium intake in the intervention group based
on lactose digestion status. There were no differences in changes in dietary calcium intake between
lactose maldigesters and lactose digesters.
4. Discussion
The results of the present study show that a school-randomized behavioral intervention did not
have any beneficial effect on dietary calcium intake and bone accretion among early adolescent girls.
On the other hand, there was a greater increase in spinal (L2–L4) bone mass over a 12-month period
and an 18-month period among lactose digesters in the intervention group compared with lactose
maldigesters in the intervention group. Thus, some benefit appears to have accrued in lactose digesters
in the behavioral intervention group; however, among the lactose maldigesters no benefit to bone mass
was seen.
These results were not consistent with the Cal-Girls study [16], which included a physical
activity component. No significant difference in change in bone mass was found in the Cal-Girls study,
whereas dietary calcium intake significantly increased over the two-year intervention period. In the
current study, the semi-quantitative food frequency questionnaire was specifically designed and
evaluated for use with Asian, Hispanic, and non-Hispanic white adolescents [25,26]. A study by
Horner et al. [28] among adult women concluded participants that underreport energy intake by
20.8% when using a comprehensive food frequency questionnaire. Thus, despite the intensive
development of the calcium food frequency questionnaire used in the present study, the calcium
intakes of participants may have included enough error to result in no differences in dietary calcium
intake between the intervention and control groups. The Cal-girls study [16] used a single 24-h
dietary recall, while DeBar and colleagues [29] used multiple days of dietary records and detected a
significant change in calcium intake. Different dietary assessment tools among the studies may account
for the discrepancies between studies. Furthermore, Golden et al. [30] suggested weight-bearing
activity and vitamin D status beneficially influence bone mineral accrual in children and adolescents.
It is possible that weight-bearing activity and vitamin D status may play a role in bone accretion;
however, data for these factors were not collected in the present study.
More Asians were in the intervention group compared with the control group. Asians may have
lower calcium intakes and bone mass compared with other ethnic groups [31]. Thus, it might be
expected that having more Asians in the intervention group would influence the difference between
dietary calcium intake and bone mass for the intervention and control groups. The FFQ used to
assess calcium intake contained unique calcium food sources traditional to Asian diets and often
missing in most dietary assessment tools used in the US [25,26]. However, a cross-sectional study
of differences and predictors of bone mass among this sample of girls found that Asian girls have a
smaller skeleton than white or Hispanic girls. Any racial/ethnic differences in BMC were found to be
mostly due to smaller size [22]. Additional work investigating variability in bone geometry among
this same sample of Asian, Hispanic, and non-Hispanic white girls concluded that ethnicity was not a
significant predictor of bone cross sectional area and section modulus [32]. After controlling for body
size and pubertal maturation, there were no differences between the ethnic groups in bone geometry.
These observations may help explain why, despite the partial ethnic group imbalance, there were
no differences in dietary calcium intake or bone mass between the intervention and control groups
at baseline, as we adjusted for known confounders.
The intervention program had a greater positive impact on bone mass for lactose digesters
compared with lactose maldigesters. Lactose maldigestion is an autosomal recessive trait which often
leads to lower calcium intake compared with lactose digesters [5–7,9], which may have resulted in the
greater increase in lumbar spine BMC in lactose digesters compared to lactose maldigesters. In the
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current study, the baseline results from two sites (California and Indiana) were previously reported by
Matlik et al. [10]. Among this sample, the prevalence of PMI was highest among the non-Hispanic white
girls (21.4%) compared to the Asian or Hispanic girls, at 19.6% and 15.8%, respectively. The results
showed that girls with PMI consumed less food calcium and had lower spinal BMC than those
without PMI. However, after inclusion of all sites and receiving a one-year intervention program,
there were no differences in changes in bone mass and dietary calcium intake between girls with PMI
and without PMI. This finding may suggest that girls with PMI may have overcome this psychological
barrier through the behavioral intervention. A decline in calcium intake is characteristic of this age
group [4]. In the intervention group, there was an attenuated reduction among the lactose digesters of
exclusively dairy calcium compared to the lactose maldigesters. The difference was not statistically
significant, however may be noteworthy.
The strengths of the current study include its large sample size representing locations throughout
the United States, high level of retention and the uniqueness of examining the influence of lactose
digestion and PMI status on dietary calcium intake and bone mass under the intervention. There were
some limitations in this study. The sample may have been biased because drinking a glass of milk was
a requirement of recruitment; thus, it is possible that participants were more likely to be milk drinkers,
which contributed to the high baseline level of calcium intake. In addition, physical activity is known
as a contributor to bone development; however, the results from the physical activity questionnaire
used in this study played no significant role in modifying the outcomes [33,34]. Therefore, this variable
was not used in any of the models. The extensive FFQ was developed exclusively for the assessment of
calcium intake; thus, the influence of other nutrients important for bone formation, such as vitamin D,
magnesium, and vitamin K were not evaluated. Our results are also limited in that we did not control
for long term UVA and UVB exposure, and serum 25(OH)D status was not included.
5. Conclusions
A school-based behavioral intervention program did not have any positive effect on dietary
calcium intake and bone mass in early adolescent girls aged 10 to 13 years. An unexpected finding
among the intervention group only was that lactose digesters had a greater increase in BMC in the
lumbar spine (L2–L4) than lactose maldigesters. Therefore, future calcium intervention trials among
early adolescents should consider LM status as a potential confounder of bone mass accretion in this
age group.
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Appendix A
Table A1. Calcium intake and bone mass among early adolescent girls in the control group based on lactose digestion status at baseline and change at first follow-up
visit at 12 months.
Baseline a 12 Months a
Adjusted Differences between Girls
in Maldigester and Digester Groups
95% Confidence
Interval
Group Difference, p
Lactose Maldigester
(n = 55)
Lactose Digester
(n = 105)
Lactose Maldigester
(n = 53)
Lactose Digester
(n = 105) ∆0–12 Months
Dietary calcium intake, mg b
Total dietary calcium 1162 ± 566 1102 ± 556 958 ± 475 1023 ± 518 95 −94 to 285 0.321
Total dairy calcium 956 ± 494 942 ± 488 788 ± 417 870 ± 456 80 −88 to 248 0.349
Exclusively dairy calcium 646 ± 415 652 ± 379 506 ± 327 607 ± 367 37 −102 to 177 0.597
Baseline a 12 Months a Adjusted Differences between Girls
in Maldigester and Digester Groups
95% Confidence
Interval
Group Difference, p
Maldigester (n = 61) Digester (n = 120) Maldigester (n = 59) Digester (n = 117) ∆0–12 Months
Bone mineral content, g c
Total body 1546 ± 368 1619 ± 374 1804 ± 416 1903 ± 390 9.29 −40.24 to 58.81 0.710
Total hip 23.11 ± 4.77 23.72 ± 4.99 25.60 ± 4.84 26.83 ± 5.02 −0.41 −0.96 to 0.13 0.136
Spine (L2–L4) 27.39 ± 7.13 27.83 ± 7.12 33.06 ± 7.67 34.15 ± 7.98 −0.42 −1.45 to 0.60 0.411
Femoral neck 3.52 ± 0.66 3.62 ± 0.68 3.89 ± 0.67 4.07 ± 0.74 −0.08 −0.17 to 0.01 0.09
a Values are means ± standard deviations; b model was adjusted for lactose maldigestion (LM), perceived milk intolerance (PMI), school blocks, race/ethnicity, baseline value for outcome,
baseline age, baseline weight, and change in weight at 12 or 18 months; girls with dietary calcium intakes <100 mg or >2500 mg were excluded as outliers and were removed from analysis;
c model was adjusted for LM, PMI, school blocks, race/ethnicity, baseline value for outcome, baseline age, baseline height, change in height at 12 or 18 months, and post-menarcheal age.
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Table A2. Calcium intake and bone mass among early adolescent girls in the control group based on lactose digestion status at 12 months and change at second
follow-up visit at 18 months.
12 Months a 18 Months a
Adjusted Differences between Girls
in Maldigester and Digester Groups
95% Confidence
Interval
Group Difference, p
Lactose Maldisgeter
(n = 53)
Lactose Digester
(n = 105)
Lactose Maldigester
(n = 53)
Lactose Digester
(n = 102) ∆12–18 Months
Dietary calcium intake, mg b
Total dietary calcium 958 ± 475 1023 ± 518 1001± 611 976 ± 469 107 −124 to 339 0.361
Total dairy calcium 788 ± 417 870 ± 456 822 ± 562 840 ± 418 82 −125 to 290 0.433
Exclusively dairy calcium 506 ± 327 607 ± 367 540 ± 430 596 ± 368 72 −95 to 238 0.395
12 months a 18 months a
Adjusted Differences between Girls
in Maldigester and Digester Groups
95% Confidence
Interval
Group Difference, p
Lactose Maldisgeter
(n = 59)
Lactose Digester
(n = 117)
Lactose Maldisgeter
(n = 57)
Lactose Digester
(n = 106) ∆12–18 Months
Bone mineral content, g c
Total body 1804 ± 416 1903 ± 390 1899 ± 388 2027 ± 391 −43.10 −88.06 to 1.87 0.060
Total hip 25.60 ± 4.84 26.83 ± 5.02 26.57 ± 4.76 28.10 ± 4.99 −0.04 −0.44 to 0.36 0.837
Spine (L2–L4) 33.06 ± 7.67 34.15 ± 7.98 35.59 ± 7.23 36.83 ± 8.10 0.11 −0.61 to 0.83 0.762
Femoral neck 3.89 ± 0.67 4.07 ± 0.74 4.05 ± 0.68 4.28 ± 0.75 −0.03 −0.10 to 0.04 0.354
a Values are means ± standard deviations; b model was adjusted for lactose maldigestion (LM), perceived milk intolerance (PMI), school blocks, race/ethnicity, baseline value for outcome,
baseline age, baseline weight, and change in weight at 12 or 18 months; girls with dietary calcium intakes <100 mg or >2500 mg were excluded as outliers and were removed from analysis;
c model was adjusted for LM, PMI, school blocks, race/ethnicity, baseline value for outcome, baseline age, baseline height, change in height at 12 or 18 months, and post-menarcheal age.
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